Olivier Benveniste Selected Research

Olivier Benveniste Research Topics

Disease

57	Myositis (Idiopathic Inflammatory Myopathies) 04/2024 - 03/2009
37	Muscular Diseases (Myopathy) 04/2024 - 11/2004
27	Dermatomyositis (Dermatopolymyositis) 01/2024 - 01/2013
15	Inclusion Body Myositis 04/2024 - 06/2011
11	Antisynthetase syndrome 02/2023 - 09/2012
10	Necrosis 04/2024 - 03/2015
10	Inflammation (Inflammations) 04/2024 - 01/2013
10	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2022 - 09/2012
8	Polymyositis 12/2018 - 03/2009
7	Fabry Disease (Fabry's Disease) 04/2024 - 01/2015
7	COVID-19 01/2022 - 01/2020
7	Neoplasms (Cancer) 01/2021 - 01/2016
7	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2011
6	Myocarditis (Carditis) 01/2024 - 07/2015
6	Muscle Weakness 12/2023 - 12/2014
5	Atrophy 01/2020 - 12/2005
5	Muscular Dystrophies (Muscular Dystrophy) 03/2019 - 10/2002
4	Myasthenia Gravis 01/2018 - 12/2005
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2015 - 10/2002
3	Stroke (Strokes) 04/2024 - 01/2015
3	Systemic Scleroderma (Systemic Sclerosis) 12/2018 - 06/2004
3	Experimental Nervous System Autoimmune Disease 10/2017 - 03/2009
2	Connective Tissue Diseases (Connective Tissue Disease) 04/2024 - 08/2013
2	Cardiomyopathies (Cardiomyopathy) 04/2024 - 02/2022
2	Renal Insufficiency (Renal Failure) 04/2024 - 01/2021
2	Hemorrhage 06/2021 - 01/2019
2	Pneumonia (Pneumonitis) 01/2021 - 01/2020
2	Exanthema (Rash) 01/2021 - 12/2018
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020 - 01/2015
2	Myocardial Infarction 01/2019 - 10/2016
2	Sarcoidosis (Schaumann Disease) 05/2018 - 07/2003
2	Disease Progression 01/2018 - 01/2015
2	Melanoma (Melanoma, Malignant) 10/2016 - 03/2016
2	Myalgia 10/2016 - 05/2015
2	Arthritis (Polyarthritis) 05/2015 - 09/2012
1	Immune System Diseases (Immune Disorders) 01/2023
1	Hypersensitivity (Allergy) 01/2023

Drug/Important Bio-Agent (IBA)

42	AntibodiesIBA 04/2024 - 10/2002
32	AutoantibodiesIBA 04/2024 - 07/2011
16	Oxidoreductases (Dehydrogenase)IBA 04/2024 - 02/2014
14	Signal Recognition ParticleIBA 04/2024 - 05/2006
11	Ligases (Synthetase)IBA 10/2022 - 06/2011
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2014
9	Proteins (Proteins, Gene)FDA Link 02/2023 - 12/2005
8	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
8	Rituximab (Mabthera)FDA Link 11/2020 - 05/2006
7	Creatine Kinase (Creatine Phosphokinase)IBA 02/2023 - 07/2011
6	InterferonsIBA 01/2021 - 07/2003
5	Immunoglobulin G (IgG)IBA 12/2023 - 06/2004
5	CytokinesIBA 01/2021 - 04/2017
5	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 04/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 07/2003
4	Cholinergic ReceptorsIBA 12/2023 - 12/2005
4	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 02/2023 - 03/2015
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2016 - 09/2012
4	DystrophinIBA 01/2015 - 10/2002
3	GlycosphingolipidsIBA 04/2024 - 09/2021
3	Sirolimus (Rapamycin)FDA Link 04/2024 - 01/2013
3	Janus Kinase InhibitorsIBA 01/2023 - 01/2018
3	ruxolitinibIBA 01/2023 - 01/2018
3	EnzymesIBA 02/2022 - 10/2016
3	Interferon Type IIBA 01/2021 - 10/2017
3	ametantrone (HAQ)IBA 01/2021 - 01/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 05/2015
3	Peptides (Polypeptides)IBA 01/2017 - 01/2015
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016 - 01/2014
2	HLA-DRB1 Chains (HLA DRB1)IBA 04/2024 - 01/2017
2	IFIH1 Interferon-Induced HelicaseIBA 08/2023 - 12/2018
2	zilucoplanIBA 02/2023 - 08/2022
2	Complement System Proteins (Complement)IBA 08/2022 - 01/2018
2	alpha-Galactosidase (Beano)IBA 02/2022 - 01/2020
2	GalactosidasesIBA 09/2021 - 01/2015
2	bimagrumabIBA 01/2021 - 01/2019
2	HLA-DR Antigens (HLA-DR)IBA 04/2019 - 10/2014
2	Monoclonal AntibodiesIBA 01/2019 - 05/2015
2	MyogeninIBA 01/2018 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2017 - 04/2017
2	SteroidsIBA 06/2011 - 12/2005
2	muskIBA 01/2008 - 12/2005
2	DNA (Deoxyribonucleic Acid)IBA 11/2004 - 10/2002
1	HLA-DQB1 antigen (HLA DQB1)IBA 04/2024
1	HLA-C Antigens (HLA-C)IBA 04/2024
1	HLA-DRB1*03:01 antigenIBA 04/2024
1	HLA-B*52:01 antigenIBA 04/2024
1	HLA-A*24:02 antigenIBA 04/2024
1	globotriaosylceramide (globotriosylceramide)IBA 04/2024
1	globotriaosyl lysosphingolipidIBA 04/2024
1	Phosphorus (Red Phosphorus)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Phosphotransferases (Kinase)IBA 12/2023
1	CreatinineIBA 12/2023
1	MyostatinIBA 02/2023
1	Abatacept (Orencia)FDA Link 01/2023

Therapy/Procedure

13	Therapeutics 01/2022 - 07/2003
4	Immunotherapy 01/2019 - 01/2015
3	Drug Therapy (Chemotherapy) 10/2017 - 05/2015
2	Plasma Exchange 12/2022 - 05/2006
2	Critical Care (Surgical Intensive Care) 12/2021 - 06/2021
2	Enzyme Replacement Therapy 11/2016 - 01/2015
2	Lasers (Laser) 01/2014 - 07/2011